Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

All Drugs Associated with Multiple allergies (Page 3)

293 drugs have been associated with Multiple allergies in FAERS reports.

Drug Reports Deaths Hosp. Life-Threat.
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM 27 0 8 0
GABAPENTIN 27 0 13 1
FLUTICASONE FUROATE 26 0 15 5
IXEKIZUMAB 26 0 1 0
LANADELUMAB 26 0 14 3
QUETIAPINE 26 0 7 0
ACLIDINIUM 25 0 19 0
SECUKINUMAB 25 0 0 0
TYSABRI 25 0 2 0
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN 24 0 9 0
PSEUDOEPHEDRINE 24 0 21 0
AZITHROMYCIN ANHYDROUS 23 9 19 9
BOSENTAN 23 3 12 0
CANAGLIFLOZIN 23 0 15 0
CODEINE 23 0 10 0
IBRUTINIB 23 0 6 0
ROFLUMILAST 23 0 21 0
UMECLIDINIUM\VILANTEROL TRIFENATATE 23 0 3 9
HYDROCHLOROTHIAZIDE 22 0 20 0
POTASSIUM 22 0 22 0
CALCIUM 21 0 19 0
KETOROLAC TROMETHAMINE 21 0 6 0
LAMOTRIGINE 21 0 4 2
LORAZEPAM 21 0 2 0
TRAMADOL 21 0 0 0
VITAMIN D NOS 21 0 17 0
BUPROPION 20 0 5 0
FEXOFENADINE 20 1 0 0
NAPROXEN 20 0 0 0
CLARITHROMYCIN 19 0 0 0
DULOXETINE 19 0 0 0
INSULIN LISPRO 19 0 4 0
METHYLPREDNISOLONE 19 0 17 0
RANITIDINE 19 0 3 1
RISPERIDONE 19 0 3 1
STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE A 19 0 0 12
LISINOPRIL 18 0 8 0
MOMETASONE FUROATE 18 0 11 0
MYCOPHENOLIC ACID 18 0 1 1
OLMESARTAN MEDOXOMIL 18 0 0 0
PIROXICAM 18 0 0 0
OLANZAPINE 17 0 15 8
SITAGLIPTIN 17 0 15 0
ASPIRIN 16 0 7 3
BUDESONIDE\FORMOTEROL\GLYCOPYRROLATE 16 0 2 1
DEXAMETHASONE 16 0 4 2
HUMAN C1-ESTERASE INHIBITOR 16 1 10 2
THEOPHYLLINE ANHYDROUS 16 0 16 0
TIRZEPATIDE 16 0 3 0
USTEKINUMAB 16 0 0 0
« 1 2 3 4 5 6 »